Market Overview

The global endoluminal suturing devices market in terms of revenue was estimated to be worth $65.70 Million in 2023 and is poised to reach $180.72 Million by 2032, growing at a CAGR of 11.9%% from 2024 to 2032.

The endoluminal suturing devices market is set to gain pace as the incidence of gastrointestinal diseases increases, along with minimally invasive surgical procedures that are on an upsurge. This is preferred by patients and healthcare providers as well, for less invasive options since preference lies in relatively pain-free surgeries with lesser hospital time and recovery periods. Advances in technology, including integration with robotic systems and improved imaging techniques, are driving developments towards more sophisticated endoluminal suturing devices for enhancing precision and efficiency during surgery.

Growth is seen geographically in North America, Europe, and the Asia-Pacific region. North America is a significant market share holder with an already well-established health care infrastructure, the presence of large-scale manufacturers, and strong adoption rates of advanced medical technologies. This is followed by Europe, where the market growth leaders are Germany and the UK. The region of Asia-Pacific is gradually becoming an attractive market with growth because of increasing healthcare expenses, increasing awareness about less invasive surgeries, and better healthcare infrastructures.

The other main attributes for the market of endoluminal suturing devices are competition through a large number of companies. Critical companies are conducting research and development to provide sophisticated products that are more functional and easy to use. Other driving factors include collaborations and partnerships of manufacturers with healthcare providers to enhance clinical results and penetrate deeper into the target markets.

Summarizing, in the coming years, endoluminal suturing devices market is going to be gigantic on account of technological enhancements, more and more demand for minimal invasive treatments, as well as incidence of gastrointestinal disorders. As a healthcare system becomes patient-centric, endoluminal suturing devices would hold the key to future surgical interventions.

Market Dynamics - Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

Constant increase in the incidence of gastrointestinal diseases such as obesity, gastroesophageal reflux disease (GERD), and IBD is one of the major drivers of the market for endoluminal suturing devices. Most of these diseases have to be treated surgically by corrective procedures and weight-loss surgeries. Higher incidences around the world, driven by an increasing number of lifestyle, dietary, and age-related issues, lead to a higher demand for effective treatment options. Over the years, minimally invasive surgery like endoluminal suturing has become highly in demand lately due to a variety of benefits compared to open surgeries. These include reduced post-surgery pains, smaller stay in the hospital and shorter recovery period. With these characteristics, the amenability to endoscopic performance can also ensure maximum precision in performing them with a minimum risk of complications; thus, patients and providers alike will be satisfied with them. Such a continuously increasing need for new innovative and efficient solutions for surgery of gastrointestinal disorders propels the adoption and development of endoluminal suturing devices into clinical practice.

Market Opportunities

Growth Potential of Endoluminal Suturing Devices in Emerging Markets

Most growth momentum is expected to come from emerging markets, as growing disposable incomes and improving healthcare infrastructure drive the market for endoluminal suturing devices. Already, in Asia-Pacific, Latin America, and Africa, economic stability is waxing and waning in such a direction that there is always increasing financial capacity to spend on most expensive medical technologies, including minimally invasive surgical approaches. With these countries' health care changes, more patients are moved toward patient-centred care, and the recovery times and surgical complications have decreased. This situation is mostly associated with growing demand in minimally invasive procedures; endoluminal suturing devices can perfectly facilitate all those. The wide luminary cavities of the human body are generally sutured within it, bringing great benefits over open surgery. Also, the awareness of minimally invasive procedures among healthcare providers and patients will result in a rapid growth of the market of endoluminal suturing devices. In addition to that, growth poses a wonderful opportunity to manufacturers to take a strong position in these emerging markets, catering to the ever-increasing needs of innovative solutions for surgery.

Key Findings:

• In 2021, Johnson & Johnson (Ethicon) announced the launch of its cutting-edge, fully operational mobile surgical lab, which will visit hospitals in 70 locations throughout the United States to give surgeons and other medical professionals the chance to learn firsthand and see the newest technologies for thoracic, bariatric, gynaecological, and colorectal procedures. Improved surgical technology and more procedures will result from this. In order to create novel solutions to meet the unmet needs in neurosurgery, Integra LifeSciences purchased Rebound Therapeutics.
• Ovesco Endoscopy AG was granted marketing authorisation for the OTSC System in Indonesia in 2019. It will be sold by ANSr SDN BHD (Malaysia), its distributor.

Market Restraining Factors

Financial Barriers to Adoption of Endoluminal Suturing Devices

The initial purchase and installation cost of endoluminal suturing devices is significant enough to pose as a major growth barrier in this market, particularly in developing regions. This is because healthcare facilities in these areas operate mainly on a trimmed budget and hence face difficulties in finding money for some of the advanced medical technologies. The high costs invested in these technologies relate to the price paid to acquire them and all additional costs, which range from the training of personnel with equipment to maintenance and infrastructure upgrades. This financial burden may delay the onset of endoluminal suturing devices because many institutions may opt for "ordering necessary equipment and procedures before expensive technologies such as endoluminal suturing devices.". In price-sensitive markets, too, the slight hesitation to invest in such technologies can be because of the lack of quick monetary returns on investment, thus making the decision-making process more cumbersome. Healthcare providers may continue to opt for the conventional surgical methods that are not unknown and less costly in terms of overall growth opportunities in the market for endoluminal suturing devices. Perhaps overcoming these major financial barriers would actually open avenues for wider acceptance and usage of such innovative solutions in surgical practice.

Segmentation Analysis

The market scope is segmented because of by Product Type, by Application, by End-User.

By Product Type

Based on the Product Type of the market is segmented into Manual Suturing Devices, Automated Suturing Devices, Accessories and Consumables.

The endoluminal suturing devices could be broadly divided into three segments which are manual suturing devices, automated suturing devices, and accessories and consumables, each targeted to a specific area of surgery. The need for direct hand manipulation by the surgeon is posed in manual suturing devices; they offer simplicity and ease of use. They are usually preferred in environments where familiarity with conventional methods is highly valued and are often appreciated among surgeons moving over to endoluminal techniques. For example, manual suturing devices can be used in gastroenterology within basic procedures as surgeons can rely on their practice with traditional suturing.

Automated suturing devices utilize the most advanced technology to make suturing faster and with greater precision, and therefore with time, much shorter operation times. They have come to be increasingly chosen in surgical environments that favour efficiency and results. One of the best examples of an automatic device is the Endo Stitch™ by Medtronic. This device enables doctors to perform quick and precise suturing through different applications, including bariatric and gastroesophageal surgeries.

Along with the major machines, there is also a market for accessories and consumables- products that also complement the major machines but are essentially sutures, clips, and guides. In general, though manual devices have a large market share, the global is shifting to automation, as producers respond to demands for efficiency and better results in surgery.

By Application

Based on the Application of the market is segmented into Gastroenterology, Urology, Pulmonology.

The vast medical domains for which application of endoluminal suturing devices exist include gastroenterology as the largest category. Gastroenterology includes intervention procedures of the gastrointestinal system, such as bariatric surgery, repair of the oesophagus, and colonic intervention. For instance, in the procedure of sleeve gastrostomy, endoluminal suturing devices help to stitch the stomach effectively so that recovery by the patient is well achieved with minimal complications.

An area in urology that is increasingly recording the application of endoluminal suturing devices is, particularly in minimally invasive surgery. They are being used for urethral reconstruction and nephrectomy surgeries wherein conventional procedures seem to carry higher risks of and have longer recovery periods for the patient.

Applications of these devices are further stretched in this area of pulmonology, particularly in lung surgeries and bronchial stent placement. This area is expanding at a rapid pace due to an increased need for minimally invasive solutions. Gastroenterology has dominated application so far, but the utility and flexibility of these endoluminal suturing devices have helped deploy across different specialties in surgery to satisfy the need for better outcomes and faster recovery times for the patient.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America is the biggest market, mainly because of the developed healthcare systems in that region, high health care spending, and a high proportion of focus on developing new surgical interventions. The key manufacturing facilities and research centres are located in the United States and Canada, which further enhance the market position. The increasing incidence of gastrointestinal disorders and growing tendency towards minimally invasive interventions have led to aggressive adoption of the endoluminal suturing system in this region.

Market growth in Europe is gradually driven by promising reimbursement policies and emphasis on innovative surgical solutions to improve patient outcomes. Advanced medical technologies, such as endoluminal suturing devices, are expected to be broadly followed by countries like Germany, France, and the UK. Therefore, increased demand for outpatient surgical procedures, along with increased awareness among the healthcare fraternity about the benefits of minimally invasive techniques, would propel market growth.

The Asia-Pacific region is likely to have the strongest growth in the endoluminal suturing devices market. Emerging economies such as China, India, and Indonesia are undergoing rapid improvements in healthcare infrastructure, increased disposable incomes, and a growing middle class, which increases access to high-tech medical technologies, including endoluminal suturing devices. An increased consciousness among patients and healthcare providers about the merits of minimally invasive procedures has, in effect, been augmenting demand in this region.

Latin America and Middle East & Africa markets are slowly growing with more people getting access to health care and increasing awareness of modern surgical practices. These countries in this region are investing in up gradation processes of the healthcare infrastructure, which also accounts for adaptation of the latest medical technologies. Demand for endoluminal suturing is advancing in urban regions where easy access to advanced health-care centres is improving.

There is a broad view of the regional overall endoluminal suturing devices market snapshot, ranging from high growth in North America and Europe to rapid development in Asia-Pacific followed by the steady development of Latin America and the Middle East & Africa. The market for endoluminal suturing devices would grow rapidly in every region based on the current healthcare system model and this global need for minimizing the invasiveness of surgery options.

Key Findings:

• According to the American Society of Metabolic and Bariatric Surgery, the number of bariatric surgery procedures performed in the United States increased from 158,000 in 2011 to almost 252,000 in 2018.

List of Companies Profiled

• Apollo Endosurgery, Inc. (U.S.)
• Johnson & Johnson (U.S.)
• Medtronic Plc (Ireland)
• Cook Group Incorporated (U.S.)
• USGI Medical (U.S.)
• Ovesco Endoscopy AG (Germany)
• Endo Tools Therapeutics S.A. (Belgium)
• ErgoSuture (U.S.)
• Sutrue Ltd. (U.K.)

Key Industry Developments

• In 2022, In Brazil, Ovesco Endoscopy AG's OTSC System was approved by ANVISA.
• In 2022, The FDA granted Endo Tools Therapeutics S.A. 510(k) clearance for the Endomina System.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Endoluminal Suturing Devices Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Endoluminal Suturing Devices market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Endoluminal Suturing Devices. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Endoluminal Suturing Devices companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Endoluminal Suturing Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Endoluminal Suturing Devices Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Endoluminal Suturing Devices Market valued?
• Which region has the largest share in 2024 for the global Endoluminal Suturing Devices Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of the Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Endoluminal Suturing Devices Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: